Amyris just moved. Here's exactly what to do next.
Who to reach, what to say, and why now — on Amyris, plus every contract, funding round, and exec hire that follows. Verified, ICP-ranked contacts on demand (email + mobile).
Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.
Amyris Awarded Agreement from BioMaP-Consortium for $12.3 million to Develop Critical Medicines
Contract Type
agreement
EmeryvilleManufacturingBiotechnologyDescription
Amyris has been awarded an agreement through the Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-C) for $12.3 million from the Administration for Strategic Preparedness and Response's (ASPR) Center for Industrial Base Management and Supply Chain (IBMSC) to advance innovative pharmaceutical manufacturing in the United States. Amyris aims to develop up to three small molecule drugs over the next two years to address the FDA drug shortage list.